Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders
Gabather AB (Nasdaq First North Growth Market: GABA) today reports that two new US provisional patent applications based on novel findings from the EEG/fMRI target engagement study with GT-002, a selective positive allosteric GABAA-receptor modulator. The inventions relate to the…
Colombia raised several issues at the WTO Ministerial Conference in Abu Dhabi
At the Thirteenth Ministerial Conference of the World Trade Organization, Colombia was involved in several highly relevant consultations. For example, the country played a key role in extending the moratorium on non-violation and situation complaints under the Agreement on Trade-Related…
